AI tech helps Taiwan doctors identify brain tumors more accurately
05/04/2021 10:48 PM
NTUH oncologist Hsu Feng-ming. CNA photo May 4, 2021
Taipei, May 4 (CNA) A technology that uses artificial intelligence has helped doctors at National Taiwan University Hospital (NTUH) identify tiny brain tumors which could easily have been missed by traditional manual contouring, the hospital said Tuesday.
At a press conference, NTUH Superintendent Wu Ming-shiang (吳明賢) described VBrain, a brain tumor auto-contouring system developed by Boston-based Vysioneer LLC, as an eagle eye.
The system has been used at NTUH for the past 18 months as part of clinical trials and helped doctors treat more than 100 patients with brain tumors, including a terminally ill woman whose lung cancer metastasized to her brain.
Digital Health Solutions from Taiwan Calls for Healthcare Rethink
published : 29 Apr 2021 at 15:00
The structure of populations across the world is changing, as many nations see a growing trend towards an ageing society.
In response to this, healthcare also needs to adapt. Accordingly, medical IoT applications have developed into a large, high potential industry, revolutionizing the provision of healthcare.
A year into the pandemic, “Taiwan still remains as one of the best managed societies against Covid-19, having one of the lowest mortality rates and one of the lowest infection rates, partially based on Taiwan’s digital health development”, remarked Dr. Yu-Chuan Jack Li, a dermatologist, professor and President-Elect of the International Medical Informatics Association, during his opening remarks.
Taiwan researchers find new use for leukemia drug against lung cancer
04/24/2021 01:28 PM
To activate the text-to-speech service, please first agree to the privacy policy below.
Tsai Hsing-chen (front row, second left), an associate professor at National Taiwan University College of Medicine. CNA photo April 22, 2021
Taipei, April 24 (CNA) Researchers at National Taiwan University Hospital (NTUH) have found that a drug used to treat leukemia can enhance the efficacy of immunotherapy for lung cancer, a discovery they said could potentially increase life expectancy for those diagnosed with the disease.
At a press conference on Thursday, the NTUH team led by Tsai Hsing-chen (蔡幸真), a doctor in the hospital s Department of Internal Medicine, highlighted the pressing need for new treatments for lung cancer, which kills over 9,000 people per year in Taiwan and is often only discovered in its later stages.
NTUH team developing treatment for lung cancer
FOUR-YEAR STUDY: A drug usually given to people with leukemia showed a side effect that might benefit those with other types of cancer, the researchers found
Staff writer, with CNA
A drug used to treat leukemia can enhance the efficacy of immunotherapy for lung cancer, researchers at National Taiwan University Hospital (NTUH) found, saying that the discovery might increase the life expectancy of those with the disease.
The team led by Tsai Hsing-chen (蔡幸真), a doctor in the hospital’s internal medicine department, told a news conference in Taipei on Thursday that new treatments for lung cancer are urgently needed, adding that the disease kills more than 9,000 people per year in Taiwan, as it is often discovered at a late stage.
Reservations for self-paid COVID-19 vaccinations open in Taiwan focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.